Spiriva campaign gets All-Star debut

Share this article:
Spiriva campaign gets All-Star debut
Spiriva campaign gets All-Star debut
Major League Baseball's annual All-Star Game last night featured new DTC spots for Spiriva HandiHaler, an inhaler indicated for chronic bronchitis and emphysema.

The television spots were created by Ogilvy Healthworld, according to a Boehringer Ingelheim spokesperson, with forthcoming digital work handled by Digitas Health. Boehringer was not able to comment on the digital component prior to launch. The media mix for the campaign is currently limited to television, according to the spokesperson.

60-second version of the spot on Spiriva's brand.com site features an upper middle-aged female actor speaking about chronic obstructive pulmonary disease (COPD): “It can be tough living with COPD, but I try not to let it slow me down.” The actor goes on to describe respiratory-intensive activities – swimming, dancing and playing hide and seek – that she enjoys, indicating that Spiriva has helped facilitate participation in those activities: “I'm breathing better with Spiriva.”

The All-Star Game aired on the FOX Network at 8pm, and included a guest appearance from President Obama, who threw the first pitch of the game and also joined announcers Joe Buck and Tim McCarver in the box. National audience numbers were not yet available from Nielsen, though preliminary data from 56 markets showed a 10.4 household rating. The National League lost the game for the thirteenth consecutive year. A Flomax billboard was almost constantly visible behind home plate.

Spiriva is distributed by Boehringer Ingelheim (BI) and marketed by BI and Pfizer in the US. Marketing duties are shared "50/50" between the two companies, according to a BI spokesperson. 
Share this article:

Email Newsletters

More in News

BI rethinks hepatitis business, posts 2013 results

BI rethinks hepatitis business, posts 2013 results

Boehringer Ingelheim says it is no longer pursuing an interferon-free combination of faldaprevir and deleobuvir.

Roche wraps quarter with two fewer pipeline medications

Roche wraps quarter with two fewer pipeline medications

Roche also announced first-quarter sales shrank 1%.

2013 favored specialists, specialty Rx

2013 favored specialists, specialty Rx

The latest IMS Institute for Healthcare Informatics assessment of 2013's prescription drug use shows that 2.3% of prescriptions account for 30% of a patient's out-of-pocket prescription costs.